Exhaled carbon monoxide in sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 25, Issue 1, 2008, Pages 46-50

  Ciarleglio, Giuseppina ^a   Refini, R M ^a   Pieroni, M G ^a   Martino, V A M ^a   Bargagli, E ^a   Rottoli, P ^a   Sestini, P ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Carbon monoxide; Carboxyhemoglobin; Interstitial lung diseases; Sarcoidosis

Indexed keywords

CARBON MONOXIDE; STEROID;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXPIRED AIR; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; NORMAL VALUE; PASSIVE SMOKING; PRIORITY JOURNAL; RADIODIAGNOSIS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SMOKING; STEROID THERAPY;

ADULT; BIOLOGICAL MARKERS; BREATH TESTS; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; DIAGNOSIS, DIFFERENTIAL; EXHALATION; FEMALE; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX;

EID: 56349141234     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nightingale JA, Maggs R, Cullinan P, et al. Airway inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit Care Med 2000; 162 (1): 161-6.
2. Slebos DJ, Ryter SW, Choi AM. Heme oxygenase-1 and carbon monoxide in pulmonary medicine. Respir Res 2003; 4 (1): 7.
3. Deveci SE, Deveci F, Acik Y, Ozan AT. The measurement of exhaled carbon monoxide in healthy smokers and non-smokers. Respir Med 2004; 98 (6): 551-6.
4. Cone DC, MacMillan DS, Van Gelder C, Brown DJ, Weir SD, Bogucki S. Noninvasive fireground assessment of carboxyhemoglobin levels in firefighters. Prehosp Emerg Care 2005; 9 (1): 8-13.
5. Morse D, Choi AM. Heme oxygenase-1: from bench to bedside. Am J Respir Crit Care Med 2005; 172 (6): 660-70.
6. Rottoli P, Magi B, Cianti R, et al. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005; 5 (10): 2612-8.
7. Horvath I, Loukides S, Wodehouse T, Kharitonov SA, Cole PJ, Barnes PJ. Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. Thorax 1998; 53 (10): 867-70.
8. Paredi P, Shah PL, Montuschi P, et al. Increased carbon monoxide in exhaled air of patients with cystic fibrosis. Thorax 1999; 54 (10): 917-20.
9. Antuni JD, Kharitonov SA, Hughes D, Hodson ME, Barnes PJ. Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax 2000; 55 (2): 138-42.
10. Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1997; 156 (4 Pt 1): 1140-3.
11. Paredi P, Leckie MJ, Horvath I, Allegra L, Kharitonov SA, Barnes PJ. Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. Eur Respir J 1999; 13 (1): 48-52.
12. Uasuf CG, Jatakanon A, James A, Kharitonov SA, Wilson NM, Barnes PJ. Exhaled carbon monoxide in childhood asthma. J Pediatr 1999; 135 (5): 569-74.
13. Vreman HJ, Wong RJ, Stevenson DK. Exhaled carbon monoxide in asthma. J Pediatr 2000; 137 (6): 889-91.
14. Yasuda H, Sasaki T, Yamaya M, et al. Increased arteriovenous carboxyhemoglobin differences in patients with inflammatory pulmonary diseases. Chest 2004; 125 (6): 2160-8.
15. Yasuda H, Yamaya M, Yanai M, Ohrui T, Sasaki H. Increased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases. Thorax 2002; 57 (9): 779-83.
16. Lakari E, Pylkas P, Pietarinen-Runtti P, Paakko P, Soini Y, Kinnula VL. Expression and regulation of hemeoxygenase 1 in healthy human lung and interstitial lung disorders. Hum Pathol 2001; 32 (11): 1257-63.
17. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/ World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16 (2): 149-73.
18. Paredi P, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide in lung disease. Eur Respir J 2003; 21 (1):197; author reply 197-8.
19. Montuschi P, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide and nitric oxide in COPD. Chest 2001; 120 (2): 496-501.
20. Togores B, Bosch M, Agusti AG. The measurement of exhaled carbon monoxide is influenced by airflow obstruction. Eur Respir J 2000; 15 (1): 177-80.
21. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6 (4): 422-8.
22. Tsuburai T, Suzuki M, Nagashima Y, et al. Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. Hum Gene Ther 2002; 13 (16): 1945-60.
23. Zhou Z, Song R, Fattman CL, et al. Carbon monoxide suppresses bleomycin-induced lung fibrosis. Am J Pathol 2005; 166 (1): 27-37.
24. Yamaya M, Sekizawa K, Ishizuka S, Monma M, Sasaki H. Exhaled carbon monoxide levels during treatment of acute asthma. Eur Respir J 1999; 13 (4): 757-60.
25. Ziora D, Kaluska K, Kozielski J. An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis. Eur Respir J 2004; 24 (4): 609-14.
26. Bergin CJ, Bell DY, Coblentz CL, et al. Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests. Radiology 1989; 171 (3): 619-24.
27. Scharte M, Bone HG, Van Aken H, Meyer J. Increased carbon monoxide in exhaled air of critically ill patients. Biochem Biophys Res Commun 2000; 267 (1): 423-6.
28. Sylvester KP, Patey RA, Rafferty GF, Rees D, Thein SL, Greenough A. Exhaled carbon monoxide levels in children with sickle cell disease. Eur J Pediatr 2005; 164 (3): 162-5.